- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
ADHD Prescriptions Soaring Among Women of Reproductive Age
The CDC reported recently that the percentage of privately insured reproductive-age women who filled a prescription for a medication for attention-deficit/hyperactivity disorder (ADHD) soared 344% from 2003 (0.9%) to 2015 (4.0%).
The CDC reported recently that the percentage of privately insured reproductive-age women who filled a prescription for a medication for attention-deficit/hyperactivity disorder (ADHD) soared 344% from 2003 (0.9%) to 2015 (4.0%).
ADHD medication prescriptions increased across all ages and US geographic regions. The increase was confined to stimulant medications.
CDC shared additional research on ADHD medication safety, including before and during pregnancy, which could help women and their healthcare providers make evidence-based decisions concerning the risks and benefits of treatment.
This is the second time the CDC has warned women to be careful of what they ingest on the chance that they become pregnant without knowing it. Two years ago, they warned women of childbearing age about the risks of drinking in case they become pregnant.
The CDC used the Truven Health MarketScan Commercial Database for the period 2003-2015 to estimate the percentage of women aged 15-44 years with private employer-sponsored insurance who filled ADHD prescriptions.
The percentage of reproductive-age women who filled at least 1 ADHD medication prescription increased 344% from 2003 (0.9% of women) to 2015 (4.0% of women). In 2015, the most frequently filled medications were mixed amphetamine salts, lisdexamfetamine, and methylphenidate.
From 2003 to 2015, the largest increase (700%) in ADHD prescriptions filled occurred among women aged 25-29 years.
In 2015, the highest percentage of ADHD medication prescriptions were filled by women in the South (4.8%) and North Central (4.0%) US regions.
The largest increase from 2003 to 2015 occurred in the South (380%).
This study did not include women on Medicaid or women who paid out-of-pocket for prescriptions. The study also did not identify a woman’s pregnancy status.
Reference
Centers for Disease Control and Prevention. Attention-deficit/hyperactivity disorder medication prescription claims among privately insured women aged 15—44 Years—United States, 2003-2015. CDC website. cdc.gov/mmwr/volumes/67/wr/mm6702a3.htm?s_cid=mm6702a3_e#suggestedcitation. Published January 18, 2018. Accessed January 22, 2018.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
Addressing Maternal Mortality in Medicaid by Focusing on Mental Health
February 15th 2023On this episode of Managed Care Cast, we speak with Inland Empire Health Plan, a managed care plan serving more than 1.4 million residents on Medi-Cal in California, about a new maternal mental health program aimed at supporting new mothers, both before they give birth and afterward.
Listen
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
May 10th 2022On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
Listen
What We’re Reading: Historic Low of Uninsured; Youth Gender Treatments; Birth Control Recall
August 4th 2023A record low of 7.7% of Americans had no health insurance at the start of 2023; the American Academy of Pediatrics renewed its backing of gender care for children while requesting a research review; 2 lots of an oral contraceptive were recalled for possible reduction in effectiveness.
Read More
Lawyers were questioned in a federal lawsuit intending to overturn approval of a drug used for medication abortion; during the COVID-19 pandemic in 2021, US maternal mortality increased for the third year in a row; the Alzheimer’s Association is lobbying Congress to push for Medicare coverage of new Alzheimer drugs under early access.
Read More
